Burra burns victim Glenn Ogg owes his renewed life to a world-first skin transplant developed at the Royal Adelaide Hospital by surgeon John Greenwood, who got sick of seeing burns patients with limited options.

BALI bombing survivor Julian Burton is issuing a final farewell to his burns charity to focus on revolutionary artificial skin technology designed to treat diabetes and end painful skin grafts.

SKIN Tissue Engineering’s Prof John Greenwood, together with Dr Marcus Wagstaff, recently won “Best in Category – Wounds” for their Poster, Changing Practice in the surgical management of major burns-delayed definitive closure, at the American Burn Association (ABA) meeting in Chicago.

SKIN Tissue Engineering was delighted to recently sponsor world leading cell culturing specialist Dr. Steven Boyce from the University of Cincinnati College of Medicine to be a key note speaker at the 2017 Australian New Zealand Burn Association Conference in Adelaide.

Dr John Greenwood is an ambassador for I Choose SA’s Future Industries and Advanced Manufacturing month. Read why he chose South Australia.

One survived a bombing in Bali, the other was the surgeon who treated him. Now, together they want to end the trauma of skin grafts.

SKIN TE’s Professor John Greenwood co-invented PolyNovo’s BTM technology for the purpose of surgical wounds and burns. This technology is now available for use for surgical wounds and burns in Australia, South Africa, the United States and New Zealand.

As part of National Burns Awareness Month (June), SKIN TE’s Julian Burton speaks to The Daily Edition about how to treat a burn.

Adelaide doctors Professor John Greenwood (SKIN TE) and Professor Toby Coates believe they’re close to creating a world first treatment for type 1 diabetes that could eliminate the need for insulin injections.

Professor John Greenwood recently presented ‘Bringing Burn Care into the 21st Century’ at the Kennedy Institute of Rheumatology in Headington, Oxford on 21 June 2017. The talk, an update to the Hunterian Lecture delivered last November in London, was well received and has stimulated further calls for BTM and CCS to be available soon in the UK.